Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
20 results
D1.136 - Allergen awareness of patients in allergology consultations at the pneumophthisiology department of the Ignace Deen University Hospital
D1.134 - Mapping the Patient’s Journey Prior to Allergen Immunotherapy
D1.135 - ”Bee Pollen” as a Potential Trigger for Anaphylaxis: A Case Study
D1.137 - Characterization of Pana g 1, a novel allergen from Korean ginseng, Panax ginseng triggering Pollen-Food Allergy Syndrome
D1.138 - IgE cross-reactivity between grass species in the presence of Japanese cedar pollen sensitization
D1.139 - Staphylococcus aureus (carriage and sensitization) - is it a significant factor in allergic rhinitis?
D1.144 - Global variations of IgE cross-reactivity in Cupressus allergy
D1.145 - A Clinical Decision Support System (CDSS) based on Machine Learning for the diagnosis of Seasonal Allergenic Rhinitis (SAR) and patient-tailored AIT prescription
D1.148 - Heterogeneity of sensitization profiles between Central and Southern European allergic patients
D1.428 - Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation
D1.431 - Associations of the composition of intestinal microbiota with the initial manifestations of IgE-mediated food allergy in children 6-12 months old
D1.433 - The effect of preventive administration of probiotic strain E. coli 083:H24:K31 on selected immune characteristics of eight-year-old children
D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention
D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)
D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)
D3.392 - What information and education is crucial for people with food allergies?
D3.393 - Daily life with a peanut allergy, as a young adult- an interview study
D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy
D3.395 - Evaluation for suspected penicillin allergy - the patient perspective
D3.398 - Food provision experience of inpatients with adverse food reactions in the acute hospital setting
Download the app
The congress at your fingertips
Available on
Download